Stockreport

Histogenics Corporation Provides NeoCart® Phase 3 Clinical Trial Enrollment Update

HISTOGENICS CORP COMMON  (HSGX) 
Last histogenics corp common earnings: 8/9 04:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.histogenics.com
PDF WALTHAM, Mass., Oct. 24, 2016 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq:HSGX), a regenerative medicine company focused on developing and commer [Read more]